TETRAMAX Trademark

Trademark Overview

On Thursday, April 6, 2017, a trademark application was filed for TETRAMAX with the United States Patent and Trademark Office. The USPTO has given the TETRAMAX trademark a serial number of 87401518. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 29, 2021. This trademark is owned by Abpro Corporation. The TETRAMAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development and related to the field of antibody therapeutics generation; Research services using a platform of biological research tools and techniques to speed development of different bispecific antibodies and related recombinant protein molecules; Novel design and engineering of antibodies; Design and engineering of antigens and immunogens; Antigen generation technological platform through synthetic biology; Platform using computer software platforms for analysis of bioinformatics data; Antibody engineering of bispecific antibodies and variants using next-generation methods; Biochemical research and development; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research in the field of immunology, synthetic biology, genetics and genetic engineering
tetramax

General Information

Serial Number87401518
Word MarkTETRAMAX
Filing DateThursday, April 6, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 29, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 26, 2017

Trademark Statements

Goods and ServicesResearch and development and related to the field of antibody therapeutics generation; Research services using a platform of biological research tools and techniques to speed development of different bispecific antibodies and related recombinant protein molecules; Novel design and engineering of antibodies; Design and engineering of antigens and immunogens; Antigen generation technological platform through synthetic biology; Platform using computer software platforms for analysis of bioinformatics data; Antibody engineering of bispecific antibodies and variants using next-generation methods; Biochemical research and development; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research in the field of immunology, synthetic biology, genetics and genetic engineering
Pseudo MarkTETRA MAX

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 13, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbpro Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801
Party NameAbpro Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801

Trademark Events

Event DateEvent Description
Monday, March 29, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 29, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 7, 2020EXTENSION 5 GRANTED
Monday, July 13, 2020EXTENSION 5 FILED
Thursday, August 6, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 13, 2020TEAS EXTENSION RECEIVED
Saturday, February 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 20, 2020EXTENSION 4 GRANTED
Thursday, February 20, 2020EXTENSION 4 FILED
Thursday, February 20, 2020TEAS EXTENSION RECEIVED
Wednesday, August 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2019EXTENSION 3 GRANTED
Monday, August 19, 2019EXTENSION 3 FILED
Monday, August 19, 2019TEAS EXTENSION RECEIVED
Monday, August 12, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 12, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 15, 2019EXTENSION 2 GRANTED
Friday, February 15, 2019EXTENSION 2 FILED
Friday, February 15, 2019TEAS EXTENSION RECEIVED
Tuesday, August 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 3, 2018EXTENSION 1 GRANTED
Friday, August 3, 2018EXTENSION 1 FILED
Friday, August 3, 2018TEAS EXTENSION RECEIVED
Tuesday, February 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 26, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 7, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 28, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2017NON-FINAL ACTION E-MAILED
Wednesday, June 28, 2017NON-FINAL ACTION WRITTEN
Tuesday, June 27, 2017ASSIGNED TO EXAMINER
Friday, April 14, 2017NOTICE OF PSEUDO MARK E-MAILED
Thursday, April 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 11, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 11, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 10, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

tetramax research engineering development platform using generation antibodies fields synthetic biology